|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.100 EUR | +0.92% |
|
0.00% | -25.17% |
| 06-04 | Equities trend higher; banks lead gains on the MIB | AN |
| 05-22 | European markets rebound; STM and Stellantis lead gains | AN |
| Market Cap | 9.29M 10.7M 8.56M 8.02M 14.99M 1.02B 15.3M 102M 39.54M 494M 40.17M 39.31M 1.72B | P/E Ratio 2024 |
30.8x | P/E Ratio 2025 | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 9.58M 11.04M 8.83M 8.28M 15.46M 1.06B 15.79M 105M 40.79M 510M 41.45M 40.56M 1.77B | EV / Sales 2024 |
1.79x | EV / Sales 2025 | 1.32x |
| Free-Float |
18.98% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.92% | ||
| Current month | +0.92% | ||
| 1 month | -2.22% | ||
| 3 months | -5.17% | ||
| 6 months | -26.42% | ||
| Current year | -25.17% |
| 1 week | 1.07 |  | 1.11 |
| 1 month | 1.06 | | 1.18 |
| Current year | 1.01 | | 1.6 |
| 1 year | 1.01 | | 1.8 |
| 3 years | 0.88 | | 1.8 |
| 5 years | 0.88 | | 3.3 |
| 10 years | 0.88 | | 3.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 55 | 01/01/2013 |
| Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 55 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-16 | Sell | Chief Executive Officer | 322,000 | 3.5778% | ||
| 12-16 | Sell | Chief Executive Officer | 968,000 | 10.7556% | ||
| 29/06/22 | Others | Chief Executive Officer | 300,000 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | 0.00% | -8.71% | -6.78% | 10.7M | |
| -1.32% | +1.28% | +41.11% | +157.32% | 1,035B | |
| +0.60% | +3.16% | +53.28% | +50.18% | 574B | |
| +0.04% | -0.93% | +17.00% | +63.45% | 397B | |
| +0.58% | +0.77% | +21.19% | +15.95% | 324B | |
| -0.85% | -2.86% | +22.05% | +13.80% | 281B | |
| +0.44% | +3.48% | +24.48% | +34.39% | 278B | |
| +1.66% | +5.61% | -44.67% | -47.49% | 193B | |
| +0.04% | +1.21% | +19.01% | +62.77% | 191B | |
| -1.09% | -3.47% | +11.27% | +60.13% | 156B | |
| Average | +0.12% | +1.07% | +15.60% | +40.37% | 342.99B | |
| Weighted average by Cap. | -0.22% | +2.39% | +28.14% | +72.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.03M 6.95M 5.56M 5.21M 9.73M 666M 9.94M 66.33M 25.68M 321M 26.1M 25.53M 1.12B | 9.73M 11.21M 8.97M 8.41M 15.7M 1.07B 16.03M 107M 41.43M 518M 42.1M 41.19M 1.8B |
| Net income | 353K 407K 325K 305K 569K 38.93M 581K 3.88M 1.5M 18.77M 1.53M 1.49M 65.25M | 737K 849K 679K 637K 1.19M 81.32M 1.21M 8.1M 3.14M 39.2M 3.19M 3.12M 136M |
| Net Debt | 5.77K 6.65K 5.32K 4.98K 9.31K 636K 9.5K 63.41K 24.55K 307K 24.95K 24.41K 1.07M | 295K 340K 272K 255K 477K 32.6M 487K 3.25M 1.26M 15.71M 1.28M 1.25M 54.63M |
Employees
50
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 1.100 € | +0.92% | 36,000 |
| 11/06/26 | 1.090 € | -0.46% | 25,000 |
| 10/06/26 | 1.095 € | 0.00% | 0 |
| 09/06/26 | 1.095 € | 0.00% | 11,000 |
| 08/06/26 | 1.095 € | -0.45% | 21,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
Select your edition
All financial news and data tailored to specific country editions
